Stay updated on Navarixin and Pembrolizumab Combination Clinical Trial

Sign up to get notified when there's something new on the Navarixin and Pembrolizumab Combination Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Navarixin and Pembrolizumab Combination Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; removed the earlier notices for v3.4.1 and the government funding status message.
    Difference
    0.4%
    Check dated 2026-02-11T09:42:14.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Added a government funding lapse notice about NIH operations and updated the page to revision v3.4.1. The previous revision v3.4.0 was removed.
    Difference
    0.4%
    Check dated 2026-02-04T06:40:59.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Glossary toggle is now visible, and the page metadata has been updated to include a new 'Last Update Submitted that Met QC Criteria' entry and a revised revision to v3.4.0, along with the addition of a 'No FEAR Act Data' note; the previous QC label, FEAR Act data label, and the older v3.3.4 revision were removed.
    Difference
    0.2%
    Check dated 2026-01-28T04:37:41.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision notes show v3.3.4 added and v3.3.3 removed, indicating a minor behind-the-scenes update rather than changes to study data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T01:42:51.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    A new Locations section lists additional study sites in the United States, Australia, Canada, and Israel, expanding where the trial is available. The HHS Vulnerability Disclosure link and several location-specific pages were removed as part of a site cleanup.
    Difference
    1%
    Check dated 2025-12-23T08:50:03.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    Revision: v3.3.2 replaces v3.3.1; no other changes to study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T16:56:15.000Z thumbnail image

Stay in the know with updates to Navarixin and Pembrolizumab Combination Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Navarixin and Pembrolizumab Combination Clinical Trial page.